Outsourcing Outlook

Gene Logic acquires TherImmune Research Corp. as part of its plan to create a new business model; First quarter results are a mixed bag for contract services companies.

External Link - article-59283.pdf

Articles in this issue

about 23 years ago

Article

June 2003

about 23 years ago

Article

From Genome Exploration to Drug Development

about 23 years ago

Article

Are you ready for Gen3

about 23 years ago

Article

Enhancement of the Dissolution Rate and Bioavailability of Glipizide through Cyclodextrin Inclusion Complex

about 23 years ago

Article

Formulation Development of a Nucleotide Phosphoramidate

about 23 years ago

Article

Behavior of Uptake of Moisture by Drugs and Excipients under Accelerated Conditions of Temperature and Humidity in the Absence and the Presence of Light

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Outsourcing Outlook

Articles in this issue

Related Content

Optimizing Impact for Rare Diseases

Tom Sellig on CDMO Innovation and US Manufacturing Growth

Generic GLP-1s Enter Canadian Market

Pharma Fundamentals: Utilizing Artificial Intelligence in Drug Development

Facility Design for Optimized Contract Manufacturing

Trending on Pharmaceutical Technology

FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps

Germany Pharma Tariff Threat: What Manufacturers Need to Know

Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next

PharmTech Weekly Roundup—June 19, 2026

Why the First Generic Single-Dose Flu Antiviral Approval Matters